Sanguinarine, a new antiplaque agent: retention and plaque specificity.
about
Polymorphic nucleic Acid binding of bioactive isoquinoline alkaloids and their role in cancer.Efficacy of a commercially available multi-herbal formulation in periodontal therapyRise and fall of oral health products with Canadian bloodroot extract.Biophysical aspects and biological implications of the interaction of benzophenanthridine alkaloids with DNA.Comparative in vitro activity of sanguinarine against oral microbial isolates.Synthesis and antimicrobial activity of chiral quaternary N-spiro ammonium bromides with 3',4'-dihydro-1'H-spiro[isoindoline-2,2'-isoquinoline] skeleton.Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation.Antimicrobial management of primary root carious lesions: a review.The effect of sanguinarine on human peripheral blood neutrophil viability and functions.The association between Viadent use and oral leukoplakia--results of a matched case-control study.Inhibition of peptidase and glycosidase activities of Porphyromonas gingivalis, Bacteroides intermedius and Treponema denticola by plant extracts.Sorption studies of dipotassium clorazepate salt (Tranxène) and midazolam hydrochloride (Hypnovel) in polyvinyl chloride and glass infusion containers.Modifications of hydrophobicity, in vitro adherence and cellular aggregation of Streptococcus mutans by Helichrysum italicum extract.
P2860
Q34043401-1B93E088-0023-4397-90EB-4D8BAF215F96Q37020266-1C00AA33-02A4-4D02-9108-27851C35320DQ37982683-3569EA37-071C-47C4-A7F8-86B5C7DB15FBQ39310190-4436783A-2005-4E71-A014-55916B77AA73Q39849772-D7125845-629F-4677-A353-75B9FC2BD3D7Q40970616-5E5D4C18-AF4F-4C7C-A737-1E3B749DF95DQ41075262-8FC473D9-8581-455B-81EB-254FDFF85AC2Q41695278-DACCD8D3-F4DD-4815-B816-948D11ABED98Q42474002-B9A4678D-05B9-49BA-947F-2FB57B9EAC0CQ44103024-872F3D3F-585D-453F-A04B-D41D8720F718Q44685525-91040000-AC57-414B-972A-C57F655D7BCFQ51686414-8D53BE8E-F6D1-417C-A926-F55A1D9560A1Q53720342-5B595573-E7DC-45F3-A324-6AD4FD3CABB7
P2860
Sanguinarine, a new antiplaque agent: retention and plaque specificity.
description
1984 nî lūn-bûn
@nan
1984 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի մարտին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Sanguinarine, a new antiplaque agent: retention and plaque specificity.
@ast
Sanguinarine, a new antiplaque agent: retention and plaque specificity.
@en
Sanguinarine, a new antiplaque agent: retention and plaque specificity.
@nl
type
label
Sanguinarine, a new antiplaque agent: retention and plaque specificity.
@ast
Sanguinarine, a new antiplaque agent: retention and plaque specificity.
@en
Sanguinarine, a new antiplaque agent: retention and plaque specificity.
@nl
prefLabel
Sanguinarine, a new antiplaque agent: retention and plaque specificity.
@ast
Sanguinarine, a new antiplaque agent: retention and plaque specificity.
@en
Sanguinarine, a new antiplaque agent: retention and plaque specificity.
@nl
P2093
P1476
Sanguinarine, a new antiplaque agent: retention and plaque specificity.
@en
P2093
Boulware RT
Groznik WJ
Southard GL
Walborn DR
Yankell SL
P304
P356
10.14219/JADA.ARCHIVE.1984.0022
P407
P577
1984-03-01T00:00:00Z